Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents Post author:Sam Post published:May 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like TherapeuticsMD Announces Webcast Of Investor Day On March 1 February 15, 2017 Novartis AG's Talent Woes Continue as Seattle Genetics Poaches a Top CAR-T Exec March 30, 2017 InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold March 27, 2017
InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold March 27, 2017